This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignees: Korea Institute of Machinery & Materials, Samsung Electronics Ltd., Uxn Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 364 
1 out of 5,871 
1 out of 4 Years Active: 2026
Title: Sejin Park - Innovator in Continuous Glucose Monitoring Technology
Introduction
Sejin Park is a notable inventor based in Suwon, South Korea. She has made significant contributions to the field of medical technology, particularly in the development of continuous glucose monitoring devices. Her innovative work aims to improve the quality of life for individuals managing diabetes.
Latest Patents
Sejin Park holds a patent for an implantable continuous glucose monitor device. This device features a continuous glucose monitor (CGM) sensor that includes a glucose oxidation electrode and a counter electrode, without the use of a glucose-specific enzyme. The glucose oxidation electrode is designed with a nanoporous layer comprising metal nanoparticles. The CGM sensor generates an electrical signal indicative of glucose oxidation in a liquid containing glucose, correlating with the effective surface area of the metal nanoparticles in the nanoporous layer. When implanted in a subject's body, an AC voltage is applied between the glucose oxidation electrode and the counter electrode, allowing for impedance measurement. This innovative approach enables the determination of glucose levels without relying on information related to the sensor's glucose sensitivity over time.
Career Highlights
Sejin Park is currently associated with Uxn Co., Ltd., where she continues to advance her research and development efforts in medical devices. Her work is pivotal in enhancing the accuracy and reliability of glucose monitoring technologies.
Collaborations
Sejin collaborates with her coworker, Sun Kil Kang, who plays a vital role in their joint efforts to innovate in the field of glucose monitoring.
Conclusion
Sejin Park's contributions to the development of continuous glucose monitoring technology exemplify her commitment to improving healthcare solutions. Her innovative patent reflects her dedication to enhancing the lives of individuals with diabetes through advanced medical technology.